AstraZeneca · 6 hours ago
External Scientific Engagement Director, Obesity
AstraZeneca is advancing a tailored approach to Obesity and Weight Management, uniting science, medical and commercial excellence to deliver durable outcomes. As the External Scientific Engagement Director for Obesity, you'll play a pivotal role in shaping the future of obesity care by driving partnerships and strategic initiatives to improve healthcare delivery and patient outcomes.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Drive partnerships with scientific societies and healthcare system decision makers to improve healthcare delivery around the world, both from a brand specific and CVRM-wide perspective
Identify and lead strategic advocacy and engagement plans with KEEs to develop experts who can participate in global, regional and local medical activities outlined in the CVRM Strategic Plans
Strategically drive external initiatives through grants and sponsorships that support patient engagement, disease state education, policy issues, that are aligned with franchise and business ambition
Map clinical guideline across the CVRM space, along with preparation and communication around key updates, and create plans to drive clinical guideline implementation at global levels
Work within the Medical affairs team to develop and execute impactful medical education that includes new clinical evidence, RWE, and guideline recommendations to increase HCP confidence in our CVRM portfolio and improve patient outcomes
Qualification
Required
Bachelor's and advanced degree (MS, MD, PharmD, PhD, or equivalent) preferred
6+ years of experience within the biopharmaceutical industry, ideally within externally-facing or Medical Affairs positions
Understanding of healthcare systems and experience in partnering and collaborating with external healthcare professionals and/or scientific societies
Demonstrated track record in delivering new solutions and driving across cross functional teams
Good scientific knowledge experience in CVRM diseases, specifically knowledge of the obesity area preferred
Experience with the USA health care system preferred
Must exhibit leadership skills, ability to perform in fast paced environments and ability to influence without authority
Visionary in their ideas for shaping AstraZeneca's external leadership, along with partnerships to advance global healthcare improvements in the CVRM space
Strong entrepreneurial spirit in shaping new ideas into tangible deliverables with measured impact on patient health
Advanced organisational skills and ability to work in a highly matrix environment with ability to timely manage multiple projects and manage many cross functional stakeholders
Proven ability to engage, influence and build effective relationships with KEEs, across functional and geographic boundaries to drive the Medical Educational strategy
Understanding and ability to navigate the external healthcare system with KEEs, scientific societies, and healthcare professionals
Enthusiastic, resilient, and flexible approach to work. Able to think innovatively and operate without clear answers in place
Strong verbal and written communication skills in English with ability to present in front of external and internal stakeholders
High ethical standards
Preferred
Good scientific knowledge experience in CVRM diseases, specifically knowledge of the obesity area preferred
Experience with the USA health care system preferred
Location; strong preference for Boston, Massachusetts, USA
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-14
Company data provided by crunchbase